Incidence of Prostate cancer climbs

excerpt of Beckers Hospital Review, read full article here
By: Elizabeth Gregerson

Following almost a decade of decline, prostate cancer incidence in the U.S. increased 3.0% per year between 2014 through 2021, according to a report published (CA: A Cancer Journal for Clinicians) September 2, 2025. Incidence of advanced-stage prostate cancer at diagnosis had the highest rate of increase at about 4.7% per year. At the same time, prostate cancer mortality continued to decline, though at a slower rate than the previous two decades. For the report, researchers analyzed cancer incidence and mortality data collected by the CDC and the National Cancer Institute through 2021 and 2023, respectively.

Here are some things to know:

In 2025, researchers estimate 313,780 people will be diagnosed with prostate cancer and 35,770 will die from the disease.

Prostate cancer accounts for 30% of all male cancers and is the second-leading cause of cancer death for men, behind lung cancer.

Among earlier-stage diagnoses, five-year prostate cancer survival rates can be near 100%, according to a Sept. 2 news release from the American Cancer Society.

Black men had a 67% higher incidence rate and a twofold higher prostate cancer mortality rate compared to white men.

Native American men had a 13% lower incidence rate and a 12% higher prostate cancer mortality rate compared to white men.

Read full article and report at Beckers Hospital Review.